TME-SW
01698
BOSS ZHIPIN-W
02076
XIAOMI-W
01810
TENCENT
00700
ALI HEALTH
00241
HK Stock MarketDetailed Quotes
02587 HEALTHYWAY INC
- 0.000
- 0.0000.00%
Trading Dec 19 09:30 CST
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.00052wk High0.00P/B0Float Cap0.00052wk Low--Dividend TTM0Shs Float0.000Historical High--Dividend LFY0.00%Amplitude0.000Historical Low--Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
HEALTHYWAY INC Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | |||||||
| Earning before tax | 41.36%-63.15M | -24.59%-320.95M | -33.03%-107.69M | -69.38%-257.61M | ---80.95M | -158.97%-152.08M | ---58.73M |
| Profit adjustment | |||||||
| Attributable subsidiary (profit) loss | 321.83%315K | 108.08%72K | -362.96%-142K | -895.54%-891K | --54K | -76.32%112K | --473K |
| Impairment and provisions: | -97.02%25K | -21.40%169K | 24.81%840K | -78.84%215K | --673K | 184.59%1.02M | --357K |
| -Impairmen of inventory (reversal) | -167.30%-107K | -157.81%-222K | -29.33%159K | 3,940.00%384K | --225K | -125.00%-10K | --40K |
| -Impairment of trade receivables (reversal) | -80.62%132K | 331.36%391K | 52.01%681K | -116.47%-169K | --448K | 223.66%1.03M | --317K |
| Asset sale loss (gain): | ---- | -116.14%-361K | -100.13%-3K | 902.69%2.24M | --2.24M | 443.08%223K | ---65K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -116.14%-361K | -100.13%-3K | 902.69%2.24M | --2.24M | 443.08%223K | ---65K |
| Depreciation and amortization: | 102.04%15.09M | 670.58%19.54M | 384.06%7.47M | -31.50%2.54M | --1.54M | -17.26%3.7M | --4.47M |
| -Depreciation | 16.55%2.52M | 106.15%4.63M | 67.67%2.16M | -27.84%2.25M | --1.29M | -29.62%3.11M | --4.42M |
| -Amortization of intangible assets | 136.88%12.57M | 5,025.09%14.91M | 1,997.23%5.31M | -50.76%291K | --253K | 994.44%591K | --54K |
| Financial expense | 45.15%2.32M | 106.21%3.25M | 145.62%1.6M | 36.03%1.58M | --651K | -34.90%1.16M | --1.78M |
| Exchange Loss (gain) | -83.04%458K | -74.19%1.25M | -28.78%2.7M | 430.94%4.84M | --3.79M | 69.55%-1.46M | ---4.8M |
| Special items | -50.45%62.99M | 21.26%324.78M | 83.24%127.13M | 78.70%267.83M | --69.38M | 41.55%149.88M | --105.88M |
| Operating profit before the change of operating capital | -43.44%18.05M | 33.85%27.76M | 1,317.86%31.91M | 714.21%20.74M | ---2.62M | -94.84%2.55M | --49.38M |
| Change of operating capital | |||||||
| Inventory (increase) decrease | -986.04%-16.33M | -1,521.88%-7.79M | -89.42%-1.5M | -152.46%-480K | ---794K | 529.58%915K | ---213K |
| Accounts receivable (increase)decrease | 137.26%17.98M | -174.86%-71.39M | -21.23%-48.25M | 26.89%-25.97M | ---39.8M | -144.32%-35.53M | ---14.54M |
| Accounts payable increase (decrease) | -97.13%1.33M | 1,505.36%88.58M | 236.44%46.11M | 40.91%5.52M | --13.71M | 133.25%3.92M | ---11.78M |
| Special items for working capital changes | 53.86%-7.06M | -467.86%-33.35M | -639.75%-15.29M | -78.69%9.07M | --2.83M | 355.41%42.54M | --9.34M |
| Cash from business operations | 7.60%13.96M | -56.97%3.82M | 148.64%12.98M | -38.38%8.87M | ---26.67M | -55.29%14.39M | --32.19M |
| Other taxs | -869.79%-931K | -158.62%-225K | -71.43%-96K | 62.82%-87K | ---56K | ---234K | ---- |
| Net cash from operations | 1.17%13.03M | -59.10%3.59M | 148.18%12.88M | -37.97%8.78M | ---26.73M | -56.02%14.16M | --32.19M |
| Cash flow from investment activities | |||||||
| Loan receivable (increase) decrease | ---- | 119.91%260K | 85.75%-100K | -1,128.35%-1.31M | ---702K | 129.53%127K | ---430K |
| Sale of fixed assets | ---- | --95K | --95K | ---- | ---- | -93.20%10K | --147K |
| Purchase of fixed assets | -238.41%-555K | -314.24%-1.19M | -343.24%-164K | 28.18%-288K | ---37K | 64.70%-401K | ---1.14M |
| Purchase of intangible assets | 32.99%-18.4M | -135.67%-37.87M | ---27.47M | -36,425.00%-16.07M | ---- | 36.23%-44K | ---69K |
| Sale of subsidiaries | ---- | 419.94%7.54M | 2,872.43%7.54M | -438.16%-2.36M | ---272K | --697K | ---- |
| Acquisition of subsidiaries | ---- | -496.68%-6.65M | ---6.65M | 62.87%-1.11M | ---- | ---3M | ---- |
| Recovery of cash from investments | 24.09%12.47M | 100.21%32.61M | 75.38%10.05M | -40.53%16.29M | --5.73M | -57.12%27.39M | --63.86M |
| Cash on investment | 28.91%-12.09M | -100.62%-32.5M | -95.40%-17M | 5.98%-16.2M | ---8.7M | 76.38%-17.23M | ---72.96M |
| Net cash from investment operations | 44.86%-18.58M | -79.15%-37.71M | -745.95%-33.69M | -379.03%-21.05M | ---3.98M | 171.25%7.54M | ---10.59M |
| Net cash before financing | 73.35%-5.55M | -178.10%-34.12M | 32.23%-20.82M | -156.54%-12.27M | ---30.71M | 0.48%21.7M | --21.6M |
| Cash flow from financing activities | |||||||
| New borrowing | -85.67%7.4M | 137.74%129.01M | 122.54%51.63M | 128.10%54.27M | --23.2M | 156.44%23.79M | --9.28M |
| Refund | 48.46%-16.7M | -317.38%-87.31M | -293.28%-32.41M | 39.03%-20.92M | ---8.24M | -93.87%-34.31M | ---17.7M |
| Interest paid - financing | -45.15%-2.32M | -106.21%-3.25M | -145.62%-1.6M | -36.03%-1.58M | ---651K | 34.90%-1.16M | ---1.78M |
| Absorb investment income | ---- | 934.91%101.38M | -96.94%300K | --9.8M | --9.8M | ---- | ---- |
| Issuance expenses and redemption of securities expenses | 93.17%-98K | -54.58%-2.5M | ---1.43M | -46.78%-1.62M | ---- | ---1.1M | ---- |
| Adjustment item of financing business | ---- | ---- | ---- | ---- | ---765K | ---- | ---- |
| Net cash from financing operations | -192.37%-13.41M | 250.56%133.09M | -35.21%14.52M | 357.19%37.97M | --22.41M | -15.04%-14.76M | ---12.83M |
| Net Cash | -201.00%-18.96M | 285.16%98.97M | 24.18%-6.3M | 270.33%25.7M | ---8.31M | -20.84%6.94M | --8.77M |
| Begining period cash | 141.96%168.69M | 58.37%69.72M | 58.37%69.72M | 18.71%44.02M | --44.02M | 30.96%37.08M | --28.32M |
| Cash at the end | 136.10%149.74M | 141.96%168.69M | 77.58%63.42M | 58.37%69.72M | --35.72M | 18.71%44.02M | --37.08M |
| Cash balance analysis | |||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | KPMG | -- | KPMG | -- | KPMG | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.